Cargando…

Intrathoracic gas effusions in patients with COVID-19

Current evidence suggests that intrathoracic gas effusions (pneumomediastinum and pneumothorax) may be observed among COVID-19 patients even without mechanical ventilation. Here, we report 9 patients who developed spontaneous intrathoracic gas effusions in the absence of mechanical ventilation. The...

Descripción completa

Detalles Bibliográficos
Autores principales: El Bozouiki, Fatima, Moumkin, Mohamed, El Melhaoui, Jihane, Hammi, Sanaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828573/
https://www.ncbi.nlm.nih.gov/pubmed/36607883
http://dx.doi.org/10.1097/MD.0000000000032605
_version_ 1784867304101642240
author El Bozouiki, Fatima
Moumkin, Mohamed
El Melhaoui, Jihane
Hammi, Sanaa
author_facet El Bozouiki, Fatima
Moumkin, Mohamed
El Melhaoui, Jihane
Hammi, Sanaa
author_sort El Bozouiki, Fatima
collection PubMed
description Current evidence suggests that intrathoracic gas effusions (pneumomediastinum and pneumothorax) may be observed among COVID-19 patients even without mechanical ventilation. Here, we report 9 patients who developed spontaneous intrathoracic gas effusions in the absence of mechanical ventilation. The incidence of spontaneous intrathoracic gas effusions is low at 0.5% in hospitalized COVID-19 patients in the absence of respiratory support. Two patients (22.2%) had spontaneous pneumomediastinum, with or without subcutaneous emphysema. Three patients (33.3%) had pneumomediastinum associated with pneumothorax, with or without subcutaneous emphysema, and 4 patients (44.4%) had spontaneous pneumothorax. The Pneumothorax was unilateral in 66.6% of cases (6/9) but without location preference. Five of our patients were smokers, of whom 80% had isolated spontaneous pneumothorax. Other comorbidities included pulmonary tuberculosis in a single patient, diabetes in 2 patients and arterial hypertension in 1 patient. None of the patients had respiratory comorbidities. All of our patients were male. The average duration of hospital stay was 10 days (±6.63). All patients required oxygen therapy. Three patients (33.3%) with spontaneous pneumothorax required chest drainage. The evolution was favorable in 6 patients (66.7%) and worse in 3 cases (33.3%). The respiratory manifestations of COVID-19 have been stereotyped. Intrathoracic effusions may also be signs of COVID-19 with varying prognoses, or even the only presentation of the disease. This should be considered in clinical practice, and doctors are encouraged to request a SARS-CoV-2 test in this situation. Further investigations with a larger sample size are needed to identify the prognostic factors in COVID-19 patients with gas effusions.
format Online
Article
Text
id pubmed-9828573
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-98285732023-01-09 Intrathoracic gas effusions in patients with COVID-19 El Bozouiki, Fatima Moumkin, Mohamed El Melhaoui, Jihane Hammi, Sanaa Medicine (Baltimore) 6700 Current evidence suggests that intrathoracic gas effusions (pneumomediastinum and pneumothorax) may be observed among COVID-19 patients even without mechanical ventilation. Here, we report 9 patients who developed spontaneous intrathoracic gas effusions in the absence of mechanical ventilation. The incidence of spontaneous intrathoracic gas effusions is low at 0.5% in hospitalized COVID-19 patients in the absence of respiratory support. Two patients (22.2%) had spontaneous pneumomediastinum, with or without subcutaneous emphysema. Three patients (33.3%) had pneumomediastinum associated with pneumothorax, with or without subcutaneous emphysema, and 4 patients (44.4%) had spontaneous pneumothorax. The Pneumothorax was unilateral in 66.6% of cases (6/9) but without location preference. Five of our patients were smokers, of whom 80% had isolated spontaneous pneumothorax. Other comorbidities included pulmonary tuberculosis in a single patient, diabetes in 2 patients and arterial hypertension in 1 patient. None of the patients had respiratory comorbidities. All of our patients were male. The average duration of hospital stay was 10 days (±6.63). All patients required oxygen therapy. Three patients (33.3%) with spontaneous pneumothorax required chest drainage. The evolution was favorable in 6 patients (66.7%) and worse in 3 cases (33.3%). The respiratory manifestations of COVID-19 have been stereotyped. Intrathoracic effusions may also be signs of COVID-19 with varying prognoses, or even the only presentation of the disease. This should be considered in clinical practice, and doctors are encouraged to request a SARS-CoV-2 test in this situation. Further investigations with a larger sample size are needed to identify the prognostic factors in COVID-19 patients with gas effusions. Lippincott Williams & Wilkins 2023-01-06 /pmc/articles/PMC9828573/ /pubmed/36607883 http://dx.doi.org/10.1097/MD.0000000000032605 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 6700
El Bozouiki, Fatima
Moumkin, Mohamed
El Melhaoui, Jihane
Hammi, Sanaa
Intrathoracic gas effusions in patients with COVID-19
title Intrathoracic gas effusions in patients with COVID-19
title_full Intrathoracic gas effusions in patients with COVID-19
title_fullStr Intrathoracic gas effusions in patients with COVID-19
title_full_unstemmed Intrathoracic gas effusions in patients with COVID-19
title_short Intrathoracic gas effusions in patients with COVID-19
title_sort intrathoracic gas effusions in patients with covid-19
topic 6700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828573/
https://www.ncbi.nlm.nih.gov/pubmed/36607883
http://dx.doi.org/10.1097/MD.0000000000032605
work_keys_str_mv AT elbozouikifatima intrathoracicgaseffusionsinpatientswithcovid19
AT moumkinmohamed intrathoracicgaseffusionsinpatientswithcovid19
AT elmelhaouijihane intrathoracicgaseffusionsinpatientswithcovid19
AT hammisanaa intrathoracicgaseffusionsinpatientswithcovid19